ASTRAZEN stock news
This page provides real-time market news, earnings updates, and company announcements related to AstraZeneca Pharma India Limited (ASTRAZEN).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-06 04:02 IST
MRK Up More Than 7% on Improved Long-Term Prospects: Still a Sell?
Finviz2026-02-13 16:51:41
Why Wedbush Believes Norway May Hold the Secret to This Quantum Computing Stock — and the Broader Sector
101 finance2026-02-14 19:39:33
Merck Indicates Better Growth Visibility in Post-Keytruda LOE Period
Finviz2026-02-16 17:48:11
EyePoint Appoints Michael Campbell as Chief Commercial Officer
Finviz2026-02-18 12:03:06
Why AstraZeneca PLC (AZN) is One of the Best Immunotherapy Stocks to Buy According to Hedge Funds
Finviz2026-02-19 14:57:44
FDA Approval For AbbVie/AstraZeneca's Combination Treatment Could Set New Standard For Slow Growing Blood Cancer
Finviz2026-02-20 13:06:49
Merck vs. Bristol Myers: Which Pharma Stock Is a Better Pick in 2026?
Finviz2026-02-20 18:06:38
Fortress Biotech's Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million
Finviz2026-02-23 13:34:18
AIM ImmunoTech Announces Planned Milestones in the Ongoing Phase 2 Trial of Ampligen and AstraZeneca's Durvalumab in the Treatment of Metastatic Pancreatic Cancer
Finviz2026-02-23 13:57:57
Tectonic Therapeutic Appoints Francois Nader, M.D., as Chair and Independent Director of the Board
Finviz2026-02-23 21:03:44
Artelo Biosciences Provides Business Update Highlighting Clinical Progress and Reports Fiscal 2025 Year-End Financial Results
Finviz2026-02-24 13:03:09
Is Johnson & Johnson Able to Maintain Its Strong Double-Digit Growth in Oncology?
101 finance2026-02-25 14:57:58
IRWD Q4 Earnings and Revenues Fall Shy of Estimates, Stock Tanks
Finviz2026-02-26 16:42:04
BMY's Stock Slumps 0.33% Despite Strong Clinical Data, Trading Volume Ranks 201st
101 finance2026-02-26 23:24:44
QUBT vs. IONQ: Which Quantum Computing Stock Has More Potential for Growth?
101 finance2026-02-27 13:51:45
Apellis Announces Mikael Dolsten, M.D., Ph.D., to Join Board of Directors
Finviz2026-03-02 12:03:46
AIM ImmunoTech Signs Agreement for Planning of a Proposed Phase 3 Clinical Trial of Ampligen in the Treatment of Late-Stage Pancreatic Cancer
Finviz2026-03-02 14:03:11
Lowe's Plummets 1.67% Amid Earnings Jitters and Sector Headwinds—What’s Next for the Home Improvement Giant?
101 finance2026-03-02 15:31:09
Pfizer Stock: Buy, Sell or Hold After Its 11% Rally So Far in 2026?
Finviz2026-03-02 17:03:10
Gilead Posts 0.73% Gain as Trading Volume Plunges 36.65% to Rank 127th in Market Activity
101 finance2026-03-02 23:06:47
Merck’s Keytruda Fuels Projected Revenue Growth for 2025: What Lies Ahead?
101 finance2026-03-03 16:10:08
CDT Positions for Transformational Growth
Finviz2026-03-04 13:33:42
Royalty Rift: Alexion Cuts Off US Royalty Payments To Xencor
Finviz2026-03-05 11:03:45
Merck (MRK) Shares Rise 1.7% Following Recent Earnings: Will the Momentum Last?
101 finance2026-03-05 17:36:45
Why AstraZeneca PLC (AZN) is One of the Best Immunotherapy Stocks to Buy According to Hedge Funds
Finviz2026-02-19 14:57:44
FDA Approval For AbbVie/AstraZeneca's Combination Treatment Could Set New Standard For Slow Growing Blood Cancer
Finviz2026-02-20 13:06:49
Merck vs. Bristol Myers: Which Pharma Stock Is a Better Pick in 2026?
Finviz2026-02-20 18:06:38
Fortress Biotech's Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million
Finviz2026-02-23 13:34:18
AIM ImmunoTech Announces Planned Milestones in the Ongoing Phase 2 Trial of Ampligen and AstraZeneca's Durvalumab in the Treatment of Metastatic Pancreatic Cancer
Finviz2026-02-23 13:57:57
Tectonic Therapeutic Appoints Francois Nader, M.D., as Chair and Independent Director of the Board
Finviz2026-02-23 21:03:44
Artelo Biosciences Provides Business Update Highlighting Clinical Progress and Reports Fiscal 2025 Year-End Financial Results
Finviz2026-02-24 13:03:09
Is Johnson & Johnson Able to Maintain Its Strong Double-Digit Growth in Oncology?
101 finance2026-02-25 14:57:58
IRWD Q4 Earnings and Revenues Fall Shy of Estimates, Stock Tanks
Finviz2026-02-26 16:42:04
BMY's Stock Slumps 0.33% Despite Strong Clinical Data, Trading Volume Ranks 201st
101 finance2026-02-26 23:24:44
QUBT vs. IONQ: Which Quantum Computing Stock Has More Potential for Growth?
101 finance2026-02-27 13:51:45
Apellis Announces Mikael Dolsten, M.D., Ph.D., to Join Board of Directors
Finviz2026-03-02 12:03:46
AIM ImmunoTech Signs Agreement for Planning of a Proposed Phase 3 Clinical Trial of Ampligen in the Treatment of Late-Stage Pancreatic Cancer
Finviz2026-03-02 14:03:11
Lowe's Plummets 1.67% Amid Earnings Jitters and Sector Headwinds—What’s Next for the Home Improvement Giant?
101 finance2026-03-02 15:31:09
Pfizer Stock: Buy, Sell or Hold After Its 11% Rally So Far in 2026?
Finviz2026-03-02 17:03:10
Gilead Posts 0.73% Gain as Trading Volume Plunges 36.65% to Rank 127th in Market Activity
101 finance2026-03-02 23:06:47
Merck’s Keytruda Fuels Projected Revenue Growth for 2025: What Lies Ahead?
101 finance2026-03-03 16:10:08
CDT Positions for Transformational Growth
Finviz2026-03-04 13:33:42
Royalty Rift: Alexion Cuts Off US Royalty Payments To Xencor
Finviz2026-03-05 11:03:45
Merck (MRK) Shares Rise 1.7% Following Recent Earnings: Will the Momentum Last?
101 finance2026-03-05 17:36:45
ASTRAZEN stock price change
On the last trading day, ASTRAZEN stock closed at 8701.50 INR, with a price change of -1.13% for the day.
Trade stock perpsASTRAZEN stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more